Literature DB >> 16449256

Significant correlations between the flow volume of patent ductus venosus and early neonatal liver function: possible involvement of patent ductus venosus in postnatal liver function.

K Murayama1, H Nagasaka, K Tate, Y Ohsone, M Kanazawa, K Kobayashi, Y Kohno, M Takayanagi.   

Abstract

BACKGROUND: The biochemical features of portosystemic venous shunt with high flow volume are hypergalactosaemia, hyperammonaemia, prolonged blood coagulation time, and raised serum bile acid concentration. The ductus venosus remains open with shunt flow in most neonates for a certain period after birth. However, the effects of blood flow through the ductus venosus on neonatal liver function remain unclear.
OBJECTIVE: To elucidate the effect of patency of the ductus venosus on liver function in early neonates.
METHODS: Subjects were divided into three groups by gestational age (group I, 29-32 weeks; group II, 33-36 weeks; group III, 37-41 weeks). The shunt flow volume through the ductus venosus was examined serially using ultrasonography, and correlations between flow volume and liver function in the respective groups were calculated during the first week after birth.
RESULTS: Group I had a higher flow volume and later functional closure than the other two groups. Plasma ammonia and serum total bile acid concentrations correlated with flow volume in groups I and II, and blood galactose and galactose 1-phosphate concentrations correlated significantly with flow volume in group III. Percentage hepaplastin also correlated significantly with flow volume in all groups, but plasma vitamin K concentration did not in any group.
CONCLUSIONS: Patent ductus venosus has a considerable effect on crucial liver functions such as ammonia detoxification, blood coagulation, and regulation of serum total bile acid concentration in early neonates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449256      PMCID: PMC2672699          DOI: 10.1136/adc.2005.079822

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  32 in total

1.  Neonatal hepatitis: a follow-up study.

Authors:  M H Chang; H C Hsu; C Y Lee; T R Wang; C L Kao
Journal:  J Pediatr Gastroenterol Nutr       Date:  1987 Mar-Apr       Impact factor: 2.839

2.  Automated enzymatic assay for plasma ammonia.

Authors:  B A Humphries; M Melnychuk; E J Donegan; R D Snee
Journal:  Clin Chem       Date:  1979-01       Impact factor: 8.327

3.  An unusual portal-systemic shunt, most likely through a patent ductus venosus. A case report.

Authors:  K Ohnishi; H Hatano; T Nakayama; K Kohno; K Okuda
Journal:  Gastroenterology       Date:  1983-10       Impact factor: 22.682

4.  Agarose gel isoelectrofocusing of UDP-galactose pyrophosphorylase and galactose-1-phosphate uridyltransferase. Developmental aspect of UDP-galactose pyrophosphorylase.

Authors:  Y S Shin; H P Niedermeier; W Endres; J Schaub; S Weidinger
Journal:  Clin Chim Acta       Date:  1987-06-30       Impact factor: 3.786

Review 5.  Are breast-fed infants vitamin K deficient?

Authors:  F R Greer
Journal:  Adv Exp Med Biol       Date:  2001       Impact factor: 2.622

6.  Perinatal bile acid metabolism: analysis of urinary unsaturated ketonic bile acids in preterm and full-term infants.

Authors:  K Maeda; A Kimura; Y Yamato; T Matsuishi
Journal:  Acta Paediatr       Date:  2003       Impact factor: 2.299

7.  Effect of protein on the determination of total bile acids in serum.

Authors:  N Q Hanson; E F Freier
Journal:  Clin Chem       Date:  1983-01       Impact factor: 8.327

8.  Determination of total bile acids in serum. A comparison of a radioimmunoassay with an enzymatic-fluorimetric method.

Authors:  B J Starkey; V Marks
Journal:  Clin Chim Acta       Date:  1982-03-12       Impact factor: 3.786

9.  Hepatitis syndrome in infancy--an epidemiological survey with 10 year follow up.

Authors:  M C Dick; A P Mowat
Journal:  Arch Dis Child       Date:  1985-06       Impact factor: 3.791

10.  Liquid-chromatographic determination of vitamin K1 in plasma, with fluorometric detection.

Authors:  Y Haroon; D S Bacon; J A Sadowski
Journal:  Clin Chem       Date:  1986-10       Impact factor: 8.327

View more
  8 in total

1.  Congenital portosystemic shunts and AMPLATZER vascular plug occlusion in newborns.

Authors:  William N Evans; Alvaro Galindo; Ruben J Acherman; Abraham Rothman; Dean P Berthoty
Journal:  Pediatr Cardiol       Date:  2009-07-23       Impact factor: 1.655

2.  Effects of patent ductus venosus on bile acid homeostasis in aryl hydrocarbon receptor (AhR)-null mice.

Authors:  Iván L Csanaky; Andrew J Lickteig; Youcai Zhang; Curtis D Klaassen
Journal:  Toxicol Appl Pharmacol       Date:  2020-07-15       Impact factor: 4.219

3.  Termination of the ligamentum venosum and the topographic relationship between the left portal vein, left hepatic artery, and ligamentum venosum in the fissures for the ligamentum teres and ligamentum venosum.

Authors:  Mi-Sun Hur; Ho-Jeong Kim; Kyu-Seok Lee
Journal:  Surg Radiol Anat       Date:  2014-09-11       Impact factor: 1.246

4.  Plasma concentrations of carbohydrates and sugar alcohols in term newborns after milk feeding.

Authors:  Laura D Brown; Claudio Cavalli; Jeri E F Harwood; Annachiara Casadei; Cecilia C Teng; Cristina Traggiai; Giovanni Serra; Giulio Bevilacqua; Frederick C Battaglia
Journal:  Pediatr Res       Date:  2008-08       Impact factor: 3.756

5.  Patent ductus venosus presenting with cholestatic jaundice in an infant with successful trans-catheter closure using a vascular plug device.

Authors:  Anith Chacko; Celeste Kock; Jayneel A Joshi; Lindi Mitchell; Samia Ahmad
Journal:  Indian J Radiol Imaging       Date:  2016 Jul-Sep

6.  Case Report: Clinical Features of Congenital Portosystemic Shunts in the Neonatal Period.

Authors:  Suhua Xu; Peng Zhang; Liyuan Hu; Wenhao Zhou; Guoqiang Cheng
Journal:  Front Pediatr       Date:  2021-12-02       Impact factor: 3.418

7.  Patent Ductus Venosus and Congenital Heart Disease: A Case Report and Review.

Authors:  Rachel Stork Poeppelman; Joseph D Tobias
Journal:  Cardiol Res       Date:  2018-10-07

8.  Investigation of Clinical Safety of Human iPS Cell-Derived Liver Organoid Transplantation to Infantile Patients in Porcine Model.

Authors:  Tomonori Tsuchida; Soichiro Murata; Shunsuke Hasegawa; Satoshi Mikami; Shin Enosawa; Huai-Che Hsu; Akinari Fukuda; Satoshi Okamoto; Akihiro Mori; Megumi Matsuo; Yumi Kawakatsu; Hitomi Matsunari; Kazuaki Nakano; Hiroshi Nagashima; Hideki Taniguchi
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.